Athanase Innovation AB

ST:ATIN Sweden Asset Management
Market Cap
$34.40 Million
Skr385.91 Million SEK
Market Cap Rank
#30297 Global
#443 in Sweden
Share Price
Skr15.90
Change (1 day)
+0.00%
52-Week Range
Skr12.00 - Skr21.80
All Time High
Skr2115.29
About

Athanase Innovation AB (publ) is public investment firm. The company invests in private and public technology and innovation companies. It also develops and sells machine inspection unit, used for automatic quality control, inspection and measurement of pallets. Athanase Innovation AB (publ) was founded in 2016 and is based in Stockholm, Sweden.

Athanase Innovation AB (ATIN) - Total Assets

Latest total assets as of September 2025: Skr488.29 Million SEK

Based on the latest financial reports, Athanase Innovation AB (ATIN) holds total assets worth Skr488.29 Million SEK as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Athanase Innovation AB - Total Assets Trend (2017–2025)

This chart illustrates how Athanase Innovation AB’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Athanase Innovation AB - Asset Composition Analysis

Current Asset Composition (June 2025)

Athanase Innovation AB's total assets of Skr488.29 Million consist of 62.4% current assets and 37.7% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr0.00 56.3%
Accounts Receivable Skr12.34 Million 2.2%
Inventory Skr12.27 Million 2.2%
Property, Plant & Equipment Skr0.00 0.0%
Intangible Assets Skr582.00K 0.1%
Goodwill Skr16.43 Million 3.0%

Asset Composition Trend (2017–2025)

This chart illustrates how Athanase Innovation AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Athanase Innovation AB's current assets represent 62.4% of total assets in 2025, an increase from 2.3% in 2017.
  • Cash Position: Cash and equivalents constituted 56.3% of total assets in 2025, up from 1.9% in 2017.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2017.
  • Asset Diversification: The largest asset category is goodwill at 3.0% of total assets.

Athanase Innovation AB Competitors by Total Assets

Key competitors of Athanase Innovation AB based on total assets are shown below.

Company Country Total Assets
Bexil Cp
PINK:BXLC
USA $29.44 Million
Norte Grande
SN:NORTEGRAN
Chile CL$2.91 Billion
BlackRock Capital Allocation Trust
NYSE:BCAT
USA $1.87 Billion
Big Tech 50 R&D-Limited Partnership
TA:BIGT
Israel ILA14.08 Million
Zhuhai Huajin Capital Co Ltd
SHE:000532
China CN¥2.38 Billion
Shaanxi International Trust Co Ltd
SHE:000563
China CN¥29.45 Billion
Sichuan Shuangma Cement Co Ltd
SHE:000935
China CN¥9.30 Billion
Sk Securities
KO:001510
Korea ₩7.28 Trillion

Athanase Innovation AB - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.01 - 0.32

Lower asset utilization - Athanase Innovation AB generates 0.32x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -13.84% - 1.00%

Negative ROA - Athanase Innovation AB is currently not profitable relative to its asset base.

Athanase Innovation AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.45 5.71 58.23
Quick Ratio 5.27 5.43 58.23
Cash Ratio 0.00 0.00 0.00
Working Capital Skr233.23 Million Skr 395.93 Million Skr 396.75 Million

Athanase Innovation AB - Advanced Valuation Insights

This section examines the relationship between Athanase Innovation AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.30
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) -19.2%
Total Assets Skr551.97 Million
Market Capitalization $6.52 Million USD

Valuation Analysis

Below Book Valuation: The market values Athanase Innovation AB's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Athanase Innovation AB's assets decreased by 19.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Athanase Innovation AB (2017–2025)

The table below shows the annual total assets of Athanase Innovation AB from 2017 to 2025.

Year Total Assets Change
2025-06-30 Skr551.97 Million -19.21%
2024-06-30 Skr683.18 Million -17.41%
2023-06-30 Skr827.25 Million -9.95%
2022-06-30 Skr918.70 Million +23577.78%
2021-06-30 Skr3.88 Million -99.43%
2020-06-30 Skr676.91 Million -2.58%
2019-06-30 Skr694.83 Million -2.29%
2018-06-30 Skr711.11 Million -0.67%
2017-06-30 Skr715.94 Million --